Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 2/20 | 0.53 |
| ▸ | FNTB | P49356 | 2/20 | 0.53 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.53 |
| ▸ | CTSK | P43235 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MME | P08473 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29788436 | 1.00 | FNTA (0.53) | FNTAFNTBPGGT1BCTSKALDH1A1 | |
| Hydrochloric Acid SCHEMBL28508695 | 0.98 | FNTA (0.52) | FNTAFNTBPGGT1BCTSKALDH1A1 | |
| SCHEMBL29788327 | 0.86 | CYP19A1 (0.47) | FNTAFNTBPGGT1BCTSKALDH1A1 | |
| SCHEMBL3451636 | 0.85 | PSMB5 (0.57) | CTSKALDH1A1LMNAMAPTPSMB5 | |
| SCHEMBL3451593 | 0.85 | PSMB5 (0.57) | CTSKALDH1A1LMNAMAPTPSMB5 | |
| SCHEMBL17833228 | 0.85 | PSMB5 (0.57) | CTSKALDH1A1LMNAMAPTPSMB5 | |
| SCHEMBL29788318 | 0.85 | CYP19A1 (0.49) | FNTAFNTBPGGT1BCTSKALDH1A1 | |
| Hydrochloric Acid SCHEMBL9697985 | 0.84 | PSMB5 (0.56) | CTSKALDH1A1LMNAMAPTPSMB5 | |
| Hydrochloric Acid SCHEMBL9696963 | 0.84 | PSMB5 (0.56) | CTSKALDH1A1LMNAMAPTPSMB5 | |
| SCHEMBL8843081 | 0.82 | PDCD1 (0.52) | ALDH1A1LMNACYP3A4MMP9MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103331151-A | Non-interpenetrating chiral MOF stationary phase, its preparation method and application in enantiomer separation in HPLC | UNIV SHANDONG NORMAL | 2013-10-02 | — | — | CN | claimed |
| US-6117841-A | USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY | WARNER-LAMBERT COMPANY (US) | 2000-09-12 | — | — | US | claimed |
| WO-1998054123-A1 | SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1998-12-03 | — | — | WO | claimed |
| CN-103331151-A | Non-interpenetrating chiral MOF stationary phase, its preparation method and application in enantiomer separation in HPLC | UNIV SHANDONG NORMAL | 2013-10-02 | — | — | CN | disclosed |
| US-6117841-A | USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY | WARNER-LAMBERT COMPANY (US) | 2000-09-12 | — | — | US | disclosed |
| WO-1998054123-A1 | SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1998-12-03 | — | — | WO | disclosed |